Drug therapy smartens up
Source abstract
Abstract
The submission of the first 'smart pill' for market approval, combined with progress in the European nanomedicine landscape, illustrates the positive outlook for drug therapy and health monitoring, explains Christian Martin.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (9)
Show source-provided references
1. Proteus Digital Health press release: U.S. FDA accepts first digital medicine New Drug Application for Otsuka and Proteus Digital Health (retrieved 2 October 2015); http://go.nature.com/ca9fAW
2. Maurer, J. M. et al. PLoS ONE 10, e0129076 (2015).10.1371/journal.pone.0129076 ↗
3. van der Schaar, P. J. et al. GIE J. 78, 520–528 (2013).
4. Blanco, E. et al. Nature Biotechnol. 33, 941–951 (2015).10.1038/nbt.3330 ↗
5. Pridgen, E. M. et al. Sci. Transl. Med. 5, 213ra167 (2013).10.1126/scitranslmed.3007049 ↗
6. Veiseh, O. et al. Nature Rev. Drug Discov. 14, 45–57 (2015).10.1038/nrd4477 ↗
7. LEEM Comité Biotechnologies Applications des nanotechnologies à la médecine (2014); http://go.nature.com/yq9K8T
8. Hay, M. et al. Nature Biotechnol. 32, 40–51 (2014).10.1038/nbt.2786 ↗
9. Wagner, V. et al. Nature Biotechnol. 24, 1211–1217 (2006).10.1038/nbt1006-1211 ↗